Skip to content

Research on the effect of cacao product intake on postprandial hyperglycemia.

Research on the effect of cacao product intake on postprandial hyperglycemia. - Effect of cacao product intake on postprandial hyperglycemia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000032750
Enrollment
50
Registered
2019-03-31
Start date
2018-05-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Oral glucose tolerance test after intake of high cacao chocolate Only oral glucose tolerance test

Sponsors

The University of Shizuoka
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Subjects who competent to consent and give voluntary consent in writing with full understanding after receiving explanation of this study aim and contents.

Exclusion criteria

Exclusion criteria: 1) Subjects who are under treatment for chronic disorders 2) Subjects whose HbA1c level is greater than 6.5% at the second screening 3) Subjects whose blood glucose level is greater than 126 mg/dl when fasting at the second screening 4) Subjects who are allergic to chocolate, milk, soybeans, wheat, beef, chicken, pork, salmon, crab, banana, apples, and oranges 5) Subjects with headache induced by intake of chocolates 6) Subjects who highly intake cacao products on a daily basis (high cacao chocolate: 70 g or more/ week, milk chocolate :140 g or more/ week) 7) Subjects taking medicines (such as hypoglycemic drugs) with function claims that potentially influence the outcome of this study on a daily basis, or those who intend to take these during this study 8) Subjects whose sexual cycle is unstable (persons with sex cycle other than 28 days) 9) Subjects who have participated in other clinical and monitoring studies within 1 month before screening or who plan to participate in other clinical trials after this clinical trial consent 10) Subjects who are pregnant, or plan to get pregnant during the study period 11) Subjects who are breast-feeding 12) Alcohol-heavy drinkers (drinkers with an average daily of over 60 g in terms of pure alcohol) 13) Subjects who are judged as ineligible by the examination director and doctors

Design outcomes

Primary

MeasureTime frame
Plasma glucose levels

Secondary

MeasureTime frame
Serum insulin levels, non-esterified free fatty acid concentration, glucagon concentration, GLP-1 concentration

Countries

Japan

Contacts

Public ContactHidekazu Arai

The University of Shizuoka Laboratory of Clinical Nutrition and Management, School of Food and Nutritional Sciences

arai@u-shizuoka-ken.ac.jp054-264-5511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026